Vaccine News and Research

Latest Vaccine News and Research

Collaborative modeling attempts could improve response to the COVID-19 pandemic

Researchers retrospectively analyzed a collaborative modeling attempt for guiding public health decisions during the COVID-19 pandemic.

8 Apr 2022

Improved seroprevalence and antibody response after third COVID-19 vaccination

Researchers evaluated the immunogenicity of a third COVID-19 vaccination in antibody deficient subjects.

8 Apr 2022

Neutralization potency against the Omicron variant of naturally expressed MBC-derived IgG antibodies from vaccinated individuals

Researchers have shown how the Omicron variant of the SARS-CoV-2 successfully evaded a large fraction of antibodies derived from memory B cells, giving rise to a reduced, but incomplete immune escape.

8 Apr 2022

Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

After the success of mRNA vaccines against COVID-19, scientists are cautiously optimistic that the same technology can be used to tackle other widespread diseases such as malaria.

7 Apr 2022

Study on the viral dynamics of Omicron and Delta infected individuals

Researchers examine the infectious periods in vaccinated individuals infected with the SARS-CoV-2 Omicron and Delta variants.

7 Apr 2022

SARS-CoV-2 mutations capable of widespread T-cell escape

A new study aimed to identify and screen the mutations observed in SARS-CoV-2 that help to facilitate CD8+ T-cell escape.

7 Apr 2022

UGA researchers develop nanotechnology-based optical sensors for rapid coronavirus detection

A University of Georgia nanotechnology research group entered the race to develop a rapid test for COVID-19 in August 2020, running experiments on a new sensor for an American manufacturing company.

7 Apr 2022

Researchers assess prevalence of SARS-CoV-2 reinfections

Researchers assessed the prevalence of SARS-CoV-2 reinfections in the Province of Modena, Italy.

7 Apr 2022

Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

A recent study analyzed the antibody that mediated the COVID-19 vaccine-induced thrombotic thrombocytopenia.

7 Apr 2022

The dynamics of the Omicron wave in England

Researchers investigated the transmission dynamics of SARS-CoV-2 VOC Omicron in England using PCR testing and genomic sequencing data from the REACT-1 study.

7 Apr 2022

Study investigates changing patterns of SARS-CoV-2 infection through Delta and Omicron waves

A new study examined whether SARS-CoV-2 infections in England varied by vaccination status, in cases with a previous COVID-19 positive test report individual, and by neighborhood socioeconomic deprivation, across the Delta and Omicron waves.

7 Apr 2022

Sotrovimab found to prevent hospitalization and mortality in COVID-19 outpatients

Researchers tested the efficacy of sotrovimab in non-hospitalized patients with SARS-CoV-2 infection.

7 Apr 2022

A shortfall of ECMO treatment cost lives during the delta surge

Speaking from his hospital bed at Vanderbilt University Medical Center in Nashville, Tennessee, James Perkinson’s voice was raspy. In February, he’d just been taken off ECMO, the last-ditch life support treatment in which a machine outside the body does the work of the heart and lungs.

7 Apr 2022

Study finds vaccines effectively reduce deaths from COVID-19 but not the prevalence of infections

Researchers in Australia have investigated COVID-19 vaccine effectiveness on the prevalence and mortality of the Delta variant.

7 Apr 2022

An assessment of COVID-19 vaccine safety during pregnancy

In a recent study posted to the Preprints with The Lancet* SSRN preprint server, researchers evaluated the safety of currently administered coronavirus disease 2019 (COVID-19) vaccines in child-bearing women.

7 Apr 2022

SARS-CoV-2 spike S375F mutation triggered the explosive spread of Omicron

In a recent study posted to the bioRxiv* preprint server, researchers investigated the mutation in the viral spike (S) protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 variant (referred to as Omicron in the present study) that is responsible for the variant’s virological features.

7 Apr 2022

Israeli research confirms BNT162b2 booster's effectiveness

Researchers explore the use of a third dose of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

6 Apr 2022

How effective are mRNA boosters against to Delta and Omicron?

The current study discusses available data on the effectiveness of mRNA vaccination against Omicron.

6 Apr 2022

COVID boosters protect you better than monoclonal antibodies, or natural infection

In a new study published in the journal Science Translational Medicine, researchers analyzed the neutralization of the Omicron BA.1 variant pseudovirus by post-vaccination serum samples.

6 Apr 2022

COVID-19 protection increases after fourth vaccine dose but declines quickly

A new study published in The New England Journal of Medicine has focussed on the relative effectiveness of the fourth dose, compared to the three doses vaccination regime, against confirmed infection and severe illness among older persons in the Israeli population.

6 Apr 2022